罗沙沙斯塔特对患有脏贫血的患者甲状腺功能的影响
Takuya Haraguchi1,2,3, Yoshiyuki Hamamoto1,2, Hitoshi Kuwata1,2
1Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka 553-0003, Japan.
The Journal of clinical endocrinology and metabolism
|August 19, 2023
概括
在患有贫血的慢性病患者中,罗沙沙斯塔特显著降低了甲状腺激素 (TSH和FT4). 另一种HIF-PH抑制剂Daprodustat对甲状腺功能没有表现出类似的影响.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 罗克萨杜沙特是一种新型的低氧诱导因子基酶 (HIF-PH) 抑制剂,用于慢性病 (CKD) 中的贫血.
- 罗沙杜沙特的结构不同于其他HIF-PH抑制剂,并且它在体外与甲状腺激素受体结合.
- 有限的数据存在于roxadustat对甲状腺功能的影响,并且不知道其他HIF-PH抑制剂是否会影响甲状腺功能.
研究的目的:
- 为了比较roxadustat和daprodustat,另一种HIF-PH抑制剂,对CKD脏贫血患者的甲状腺功能的影响.
主要方法:
- 对26名患有慢性瘤贫血的患者进行了回顾性观察性研究.
- 患者接受了roxadustat或daprodustat的治疗.
- 在治疗前和治疗后测量了甲状腺刺激激素 (TSH) 和自由甲状腺素 (FT4) 水平.
主要成果:
- 罗沙杜沙特治疗导致TSH (2.47~0.66μIU/mL) 和FT4 (0.93~0.70 ng/dL) 显著下降.
- 达普罗杜斯塔特治疗没有导致TSH (3.04~2.89μIU/mL) 或FT4 (0.93~0.97 ng/dL) 显著变化.
结论:
- 在患有脏贫血的患者中,Roxadustat显著降低了TSH和FT4水平.
- 在这种患者群体中,达普罗杜沙特似乎不会影响TSH或FT4水平.
更多相关视频
相关概念视频
01:11Renal Failure: Dose Adjustments
121
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
121
01:28Renal Drug Excretion: Tubular Secretion
220
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
220
01:15Renal Drug Excretion: Overview
183
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
183
01:25Renal Drug Excretion: Tubular Reabsorption
215
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
215
01:17Factors Affecting Renal Clearance: Renal Impairment
119
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
119
01:28Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42